Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University.

Slides:



Advertisements
Similar presentations
The house believes that positive GC NAAT results in low prevalence populations should be confirmed.
Advertisements

Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
Utilization and Quality of STD Services in Managed Care Organizations: A Synthesis of Recent Research K Irwin 1, W Lafferty 2, ER Brown 3, N Pourat 3,
Assessing the Training Needs of Managed Care Providers: Implications for STD Clinical Training Targeting this Hard-to- Reach Group by the Eastern Quadrant.
CDC Recommendations for HIV Testing of Adults and Adolescents Christina Price, MPH Delta Region AIDS Education and Training Center.
The impact of Genital Herpes on Health Status Preferences Raj Patel University of Southampton.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
HIV Testing in Health-Care Settings
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Is the chlamydia screening programme worthwhile? BRITISH SOCIETY FOR MICROBIAL TECHNOLOGY 27 th ANNUAL SCIENTIFIC MEETING 18 May 2012 Dr Angie Bone, Director.
Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.
Positive NAAT test results for Neisseria gonorrhoeae do not require routine confirmatory testing Matthew R. Golden MD, MPH Center for AIDS & STD, University.
Scaling-up of RTI services at Wardha District Using RTI Syndromic Approach Method MS. GUNJAN KINNU CEO, ZP, WARDHA.
Self-Collected Vaginal Specimens for the Detection of Multiple STIs in Adolescent Detainees Cynthia M. Holland, M.D., M.P.H., Harold C. Wiesenfeld, M.D.,
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
The Relationship Between Repeat Infections and Behavioral Risk Factors and Clinician Counseling: Findings from a Philadelphia STD Clinic M. Eberhart 1,
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
Patient-Delivered Partner Therapy for STD: Evidence and Prospects for Implementation National STD Conference 2004 Matthew Hogben, CDC Matthew R Golden,
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
CDC National Infertility Prevention Project Laboratory Update Region I Wells Beach, Maine June 1-3, 2009 Richard Steece, Ph.D., D(ABMM)
HIV Testing in Health- Care Settings Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings U.S. Centers.
Epidemiology of Chlamydia trachomatis
The HPV Vaccine Our Best Shot to Prevent Cervical Cancer Harold C. Wiesenfeld, MD,CM Department of Obstetrics, Gynecology and Reproductive Sciences-University.
Guidelines for Laboratory Testing and Result Reporting for Antibody to Hepatitis C Virus Miriam J. Alter, Ph.D. Division of Viral Hepatitis Centers for.
Expedited Partner Therapy in Wisconsin STD Control Section Wisconsin Division of Public Health June 2010.
Prevention of Complications of PID Roberta B. Ness, M.D., M.P.H. University of Pittsburgh Graduate School of Public Health.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Pelvic inflammatory disease infection Involve - (PID) is a generic term for inflammation of the uterus( (endmetritis), fallopian tubes (salpingitis), and/or.
INFERTILITY PREVENTION PROJECT (IPP) Roxanne Ereth, MPH STD Control Program Manager September 2, 2009.
March 2011 Chicago.  IDPH Laboratory Update  Rescreening  Treatment Timeliness  SBHC/JDC Chlamydia Screening Initiative  SBHC-Sports Physical Project.
Universal HIV Testing Closing the Gap Peter A. Leone, MD Associate Professor of Medicine University of North Carolina Medical Director, NC HIV/STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
Sarah E. Cavanaugh Addiction Therapy-2014 Chicago, USA August 4 - 6, 2014.
RTI International is a trade name of Research Triangle Institute Untreated chlamydial infection among adolescents and young adults in Baltimore,
Re-Screening of CT Positive Clients in Region X IPP, Goldenkranz S., 1 Fine D. 1 1 Center for Health Training 2010 CDC STD Prevention Meeting,
Faiza Ali MD, Ericka Hayes MD, Gaurav Kaushik MPH, Nicole Carr RN, Katie Plax MD Washington University School Of Medicine Department of Pediatrics.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
Region I Laboratory Update CDC National Infertility Prevention Project Boston, Massachusetts November 15, 2010 Richard Steece, Ph.D., D(ABMM) Laboratory.
JORDAN E. LAKE, MD, MSC AAHU SEPTEMBER 2014 Prevention for Positives.
When to Confirm a Positive NAAT An additional test should be considered after a positive screening test if a false-positive screening test would result.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Lower Hudson Valley Perinatal Network Serving Dutchess, Putnam, Rockland & Westchester Counties Presented at the Quarterly Education & Networking Conference.
All Slides Sexually Transmitted Disease Surveillance 2002 Division of STD Prevention.
Unprotected Sex, Chlamydia and Infertility Leah Fowler Tyler McGrath Meg Celidonia.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 1998 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
Taking a Sexual History Katherine Marx, MS, MPH, FNP-BC.
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 1999 Division of STD Prevention.
STD’s in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2001 Division of STD Prevention.
Focus Area 25 Sexually Transmitted Diseases Progress Review July 21, 2004.
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
Expedited Partner Therapy The Denver Experience Cornelis A. Rietmeijer, MD, PhD Denver Public Health Department.
STD S & P REGNANCY By: Alaysha Torres. STD S AND P REGNANCY Sexually Transmitted Disease (STD) PREG…NANCY (pregnancy)
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2007 Division of STD Prevention.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2004 Division of STD Prevention.
CT and GC Screening: What about the guys?! Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Department of Health SUNY at Buffalo School of Medicine Buffalo,
Spencer Nance PSY 328/01 April 1, 2015 Dr. Gordon Cappelletty.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
IPP Infrastructure Measures of Effectiveness: Preliminary Data and Next Steps Kelly Morrison Opdyke, MPH Region II Infertility Prevention Project Cicatelli.
Catherine M. Bettcher, M.D. CME Director & Assistant Professor, Department of Family Medicine.
Bacterial STI Screening in An Inner city HIV Clinic Adetunji Adejumo, MD; Cynthia Lee MA; Sharon Mannheimer, MD Department of Medicine, Division of Infectious.
Chlamydia screening programs: are epidemiology and mathematical modelling looking at the same thing? Nicola Low Institute of Social and Preventive Medicine.
Mayuri Dasari M.D. Cook County Loyola Provident
Prevalence of Sexually Transmitted Infections and Bacterial Vaginosis among Female Adolescents in the United States: Data from the National Health and.
Martin Goldberg1, Daniel R. Newman2, TA Peterman2,
Forest plot of various sensitivity analyses of the risk for pelvic inflammatory disease (PID), ectopic pregnancy and tubal factor infertility (TFI) between.
Presentation transcript:

Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University of Pittsburgh School of Medicine Magee-Womens Hospital

Positive Predictive Value: The Influence of Disease Prevalence Zenilman. Sex Transm Infect 2003

Positive Predictive Value: The Influence of Disease Prevalence PPV at Specificity of: Prevalence98%99%99.5% 10%84%91%95% 5%71%83%90% 2%49%66%79% 1%32%49%66% 0.5%19%32%49%

Positive Predictive Value: The Influence of Disease Prevalence 95% Sensitivity 99% Specificity PrevalenceTestTrue InfectionPPV +- 10% % (95/104) % % (38/48) % % (19/29)

BD ProbeTec Performance Multicenter Evaluation Female SwabMale Swab LabPrevalenceSPECPPV SPEC PPV IU13.4% JHU9.0% UCSF5.3%100 SJPHS4.4% UAB15.1% UMMS10.9% CCF11.5% Van Der Pol et al. J Clin Micro 2001

LCR Performance Multicenter Evaluation Female SwabMale Urine LabPrevalenceSPECPPV SPEC PPV IU13.4% JHU9.0% UCSF5.3%100 SJPHS4.4% UAB15.1% UMMS10.9% CCF11.5% Van Der Pol et al. J Clin Micro 2001

Reproducibility of BD Probe-Tec Initial MOTA Scores 2,000-9,999>10,000 Repeat Positive Repeat Negative 56 Total26181 Culler. J Clin Micro 2003

Implications of a Positive CT Test Psychosocial Impact/Stigma Negative impact on sexual relationships Future Reproductive Morbidity Cost Resource Utilization

Implications of a Positive CT Test Psychosocial Impact –Shock –Depression –Anxiety –Guilt –Isolation –Shame –Stigma (?barrier to future STD care?)

Implications of a Positive CT Test Negative impact on sexual relationships –Destroyed relationships –Accusations of infidelity –Impaired intimacy –Less sexually desirable –Less sexual enjoyment

Implications of a Positive CT Test Future Reproductive Morbidity –Increased risk of Ectopic pregnancy Tubal factor infertility Chronic pelvic pain –Neonatal transmission

Implications of a False-Positive CT Test Short-Term Costs Confirmatory Testing Additional assay Small # of specimens in low prev. populations Lab issues No Confirmatory Testing Treatment Partner notification Partner treatment Screening for other STDs Counseling time

Implications of a Positive CT Test Long-Term Costs Resource Utilization False positive tests will lead to increased utilization of healthcare services ($$$) –Repeat screening for C. trachomatis Follow national screening recommendations –Increased healthcare utilization Patient is “labelled” All pelvic pain = PID (costs of treatment) Increased surveillance for ectopic pregnancy

Implications of a False-Positive CT Test Overall Costs Confirmatory Testing Additional assay No Confirmatory Testing Treatment Partner notification Partner treatment Screening for other STDs Counseling time Repeat testing Future testing and work-up for possible STD-related illness (e.g. PID, ectopic pregnancy) Reduce costs

Is Educating Physicians on the Proper Interpretation of STD Tests a Viable Strategy?

Will Providers Properly Counsel Patients? 71% of PA primary care physicians report adequate STD training in residency (Ashton, Cook, Wiesenfeld et al. Sex Transm Dis 2002) 38% of adults were asked about STDs during routine checkups in the last year (Tao, Irwin & Kasler Am J Prev Med 2000) Only 32% of primary care physicians report screening a sexually active teen for CT (Cook, Wiesenfeld, Ashton et al. J Adol Health 2001) Only 61% of PCPs met criteria for adequate STD knowledge (Wiesenfeld, Cook et al. Unpublished data) QUALITY OF STD CARE VARIES AND IS IMPERFECT

“Clinicians must know the approximate prevalence of the condition of interest in the population being tested; if not, reasonable interpretation is impossible” David A. Grimes & Kenneth F. Shulz Uses and Abuses of Screening Tests Lancet 2002

What do the Providers Know About False Positive STD Tests? NOT MUCH! Survey of local providers: –94% underestimated the false-positive rate of a NAAT CT test in a low prevalence population –Most physicians vastly underestimated the false positive rate of CT NAAT testing: Two-thirds estimated the false positive rate of < 5% in a population where the risk of a positive test being a false positive is 50%

Do Physicians Currently Follow Recommendations Concerning False-Positive Tests? CDC (MMWR Oct 18, 2002): “Patients with positive screening test results require counseling regarding…the possibility of a false-positive result” Survey: 76% of physicians rarely (<1%) inform patients with a positive CT NAAT result that it may be a false positive

Do Physicians Currently Follow Recommendations Concerning False-Positive Tests? CDC (MMWR Oct 18, 2002): “Because therapy for CT is safe and should not be delayed, therapy can be offered while awaiting additional test results…” Survey: 18% of physicians would offer empiric treatment before or in lieu of retesting

Is Educating Physicians on the Proper Interpretation of STD Tests a Viable Strategy? Doubtful

Should Confirmatory Testing of NAATs be Routine for Chlamydia Infections in Populations with < 4% Prevalence? YES Not labor intensive Additional costs small (small #s) Reduction in costs incurred with false-positive tests (short and long-term) Eliminate unnecessary adverse psychosocial impact Feasibility of providers incorporating counseling on false-positive results is questionable Improved quality of care for our patients

“Remember: a clinician, not a laboratory test, makes a diagnosis. Overinterpretation of test results is the first cost of molecular diagnostics” Jeffrey Klausner, MD Clin Infect Dis 2004